Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Progyny, Inc.PGNY · Entity 4521 | Director · Executive Chairman | January 02, 2026 | January 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Progyny, Inc.
Report date January 02, 2026 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 238,462 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Tax withholding · Disposed 2,171 · Balance 238,462 F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2022 Filed Sep 6, 2022 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 700 | $39.20 | $27,440.00 |
DisclosureSEC source: 0001628280-22-024366 · wf-form4_166249570016850.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.03 to $39.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| September 02, 2022 Filed Sep 6, 2022 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 700 | $0.91 | $637.00 |
DisclosureSEC source: 0001628280-22-024366 · wf-form4_166249570016850.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 41,667 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-024366 · wf-form4_166249570016850.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,567,013 Underlying: Common Stock · 41,667 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 41,667 | $39.01 | $1,625,429.67 |
DisclosureSEC source: 0001628280-22-024366 · wf-form4_166249570016850.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.85 to $39.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 41,667 | $0.91 | $37,916.97 |
DisclosureSEC source: 0001628280-22-024366 · wf-form4_166249570016850.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:16 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock · Derivative | 41,666 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-022676 · wf-form4_166033534683236.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,608,680 Underlying: Common Stock · 41,666 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:16 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 12,011 | $44.78 | $537,852.58 |
DisclosureSEC source: 0001628280-22-022676 · wf-form4_166033534683236.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.56 to $44.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:16 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 24,255 | $41.19 | $999,063.45 |
DisclosureSEC source: 0001628280-22-022676 · wf-form4_166033534683236.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,559 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.55 to $44.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:16 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 3,300 | $42.98 | $141,834.00 |
DisclosureSEC source: 0001628280-22-022676 · wf-form4_166033534683236.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,814 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.54 to $43.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:16 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,100 | $42.01 | $88,221.00 |
DisclosureSEC source: 0001628280-22-022676 · wf-form4_166033534683236.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,114 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.53 to $42.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:16 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 41,666 | $0.91 | $37,916.06 |
DisclosureSEC source: 0001628280-22-022676 · wf-form4_166033534683236.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 20:36 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock · Derivative | 41,667 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-022234 · wf-form4_166016379129765.xml · derivative · entry 14 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,650,346 Underlying: Common Stock · 41,667 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 20:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 900 | $44.66 | $40,194.00 |
DisclosureSEC source: 0001628280-22-022234 · wf-form4_166016379129765.xml · nonDerivative · entry 12 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.59 to $44.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 20:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 5,200 | $43.92 | $228,384.00 |
DisclosureSEC source: 0001628280-22-022234 · wf-form4_166016379129765.xml · nonDerivative · entry 11 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,448 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.57 to $44.545, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 20:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 5,214 | $42.74 | $222,846.36 |
DisclosureSEC source: 0001628280-22-022234 · wf-form4_166016379129765.xml · nonDerivative · entry 10 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,648 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.41 to $43.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 20:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 4,986 | $42.04 | $209,611.44 |
DisclosureSEC source: 0001628280-22-022234 · wf-form4_166016379129765.xml · nonDerivative · entry 9 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,862 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.40 to $42.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 20:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 25,367 | $40.78 | $1,034,466.26 |
DisclosureSEC source: 0001628280-22-022234 · wf-form4_166016379129765.xml · nonDerivative · entry 8 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,848 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.38 to $41.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 20:36 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 41,667 | $0.91 | $37,916.97 |
DisclosureSEC source: 0001628280-22-022234 · wf-form4_166016379129765.xml · nonDerivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:36 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock · Derivative | 41,667 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-022234 · wf-form4_166016379129765.xml · derivative · entry 13 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,692,013 Underlying: Common Stock · 41,667 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 200 | $46.09 | $9,218.00 |
DisclosureSEC source: 0001628280-22-022234 · wf-form4_166016379129765.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.08 to $46.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 14,601 | $45.38 | $662,593.38 |
DisclosureSEC source: 0001628280-22-022234 · wf-form4_166016379129765.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,748 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 22,666 | $44.67 | $1,012,490.22 |
DisclosureSEC source: 0001628280-22-022234 · wf-form4_166016379129765.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,349 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.99 to $44.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 4,000 | $43.32 | $173,280.00 |
DisclosureSEC source: 0001628280-22-022234 · wf-form4_166016379129765.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,015 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.92 to $43.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 200 | $41.75 | $8,350.00 |
DisclosureSEC source: 0001628280-22-022234 · wf-form4_166016379129765.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,015 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:36 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 41,667 | $0.91 | $37,916.97 |
DisclosureSEC source: 0001628280-22-022234 · wf-form4_166016379129765.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 27, 2022 Filed Jun 29, 2022 20:50 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,452 | $31.21 | $45,316.92 |
DisclosureSEC source: 0001415889-22-007053 · form4-06292022_010600.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.22 to $31.21, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges. Read SEC document |
| June 27, 2022 Filed Feb 6, 2023 21:57 UTC Amendment | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,452 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-002435 · wf-form4a_167572063850302.xml · derivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,732,228 Underlying: Common Stock · 1,452 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested and exercisable. F4 · balance_after: The amount reported in Column 9 of Table II has been updated to reflect the number of derivative securities held by the Reporting Person as of the date of the Original Filing. Read SEC document |
| June 27, 2022 Filed Feb 6, 2023 21:57 UTC Amendment | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 1,452 | $0.91 | $1,321.32 |
DisclosureSEC source: 0001628280-23-002435 · wf-form4a_167572063850302.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This Form 4/A is being filed to reflect the stock option exercise reported in Table II, which was inadvertently omitted from the original Form 4 filing (the "Original Filing"). The total securities reported in Column 5 of Table I has also been updated to reflect the number of shares of common stock held by the Reporting Person as of June 29, 2022, the date of the Original Filing. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001415889-22-003941 · form4-04072022_010401.xml · derivative · entry 4 Schlanger David J · CIK 0001576145 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,733,680 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options are fully vested and exercisable. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 4,200 | $48.99 | $205,758.00 |
DisclosureSEC source: 0001415889-22-003941 · form4-04072022_010401.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.86 to $49.61, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 45,800 | $48.24 | $2,209,392.00 |
DisclosureSEC source: 0001415889-22-003941 · form4-04072022_010401.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,200 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.86 to $48.855, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001415889-22-003941 · form4-04072022_010401.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2022 Filed Apr 5, 2022 20:17 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-22-002587 · edgar.xml · derivative · entry 10 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,783,680 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The options are fully vested and exercisable. Read SEC document |
| April 04, 2022 Filed Apr 5, 2022 20:17 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,500 | $52.59 | $78,885.00 |
DisclosureSEC source: 0001179110-22-002587 · edgar.xml · nonDerivative · entry 8 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.31 to $52.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges. Read SEC document |
| April 04, 2022 Filed Apr 5, 2022 20:17 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,400 | $51.81 | $72,534.00 |
DisclosureSEC source: 0001179110-22-002587 · edgar.xml · nonDerivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,500 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.21 to $52.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges. Read SEC document |
| April 04, 2022 Filed Apr 5, 2022 20:17 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 6,500 | $50.58 | $328,770.00 |
DisclosureSEC source: 0001179110-22-002587 · edgar.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,900 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.15 to $51.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges. Read SEC document |
| April 04, 2022 Filed Apr 5, 2022 20:17 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 40,600 | $49.50 | $2,009,700.00 |
DisclosureSEC source: 0001179110-22-002587 · edgar.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,400 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.15 to $50.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges. Read SEC document |
| April 04, 2022 Filed Apr 5, 2022 20:17 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-22-002587 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:17 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-22-002587 · edgar.xml · derivative · entry 9 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,833,680 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The options are fully vested and exercisable. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:17 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 14,533 | $52.54 | $763,563.82 |
DisclosureSEC source: 0001179110-22-002587 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.1250 to $53.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:17 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 35,467 | $51.52 | $1,827,259.84 |
DisclosureSEC source: 0001179110-22-002587 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,533 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.12 to $52.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:17 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-22-002587 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2022 Filed Mar 5, 2022 02:43 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001104659-22-030792 · tm228503-4_4seq1.xml · derivative · entry 8 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,883,680 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| March 03, 2022 Filed Mar 5, 2022 02:43 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 50,000 | $43.67 | $2,183,500.00 |
DisclosureSEC source: 0001104659-22-030792 · tm228503-4_4seq1.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6). F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.05 to $44.83, inclusive. Read SEC document |
| March 03, 2022 Filed Mar 5, 2022 02:43 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001104659-22-030792 · tm228503-4_4seq1.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2022 Filed Mar 5, 2022 02:43 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001104659-22-030792 · tm228503-4_4seq1.xml · derivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,933,680 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| March 02, 2022 Filed Mar 5, 2022 02:43 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 33,511 | $44.51 | $1,491,574.61 |
DisclosureSEC source: 0001104659-22-030792 · tm228503-4_4seq1.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.00 to $44.91, inclusive. Read SEC document |
| March 02, 2022 Filed Mar 5, 2022 02:43 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 5,604 | $43.48 | $243,661.92 |
DisclosureSEC source: 0001104659-22-030792 · tm228503-4_4seq1.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,511 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6). F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.99, inclusive. Read SEC document |
| March 02, 2022 Filed Mar 5, 2022 02:43 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 10,885 | $42.73 | $465,116.05 |
DisclosureSEC source: 0001104659-22-030792 · tm228503-4_4seq1.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,115 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.38 to $42.99, inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6). Read SEC document |
| March 02, 2022 Filed Mar 5, 2022 02:43 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001104659-22-030792 · tm228503-4_4seq1.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.